Sort   by:  
 Page size 
UnknownThromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial.
Not available
S-EPMC3639147 | biostudies-literature
UnknownLevodopa-carbidopa intrajejunal infusion in Parkinson's disease: untangling the role of age.
Not available
S-EPMC8068706 | biostudies-literature
UnknownPathologic response and survival after neoadjuvant chemotherapy with or without pertuzumab in patients with HER2-positive breast cancer: the Neopearl nationwide collaborative study.
Not available
S-EPMC10335743 | biostudies-literature
UnknownClinical characteristics and drug-drug interactions in human epidermal growth factor receptor 2-positive breast cancer treated with trastuzumab deruxtecan: real-world data from the DE-REAL study.
Not available
S-EPMC12848230 | biostudies-literature
UnknownA multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study.
Not available
S-EPMC6343690 | biostudies-literature
UnknownA retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience.
Not available
S-EPMC5593613 | biostudies-literature
UnknownDistinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.
Not available
S-EPMC7027476 | biostudies-literature
Sort   by:  
 Page size